| Literature DB >> 35878289 |
Abstract
The aim of this literature review is to discover whether there is a relationship between exposure to dioxins and cancer incidence in the hotspot regions of Vietnam by estimating the risk ratio index. The results of the study show that the incidence of cancer (soft tissue sarcoma; Hodgkin's and non-Hodgkin's lymphoma; lung, prostate, and liver cancer) in the dioxin-exposed Vietnamese population is much higher than the results of studies published in other countries because of the high levels of dioxins in South Vietnam, where Agent Orange was sprayed during the war. Further studies on the health effects of dioxins in the Vietnamese population, including cancer incidence, should be conducted with improved research methods.Entities:
Keywords: Vietnam; cancer; dioxins; incidence; risk ratio
Year: 2022 PMID: 35878289 PMCID: PMC9320298 DOI: 10.3390/toxics10070384
Source DB: PubMed Journal: Toxics ISSN: 2305-6304
Characteristics and results (RR) of some of the epidemiological studies on relationships between dioxins and human cancer development. Reproduced from Xu et al. [14], published by Sci. Rep., 2016.
| No. | Study | Country/Cohort | Time | Exposure | Exposure | Cancer Types | Gender | No. of Cancer | Age (Years) | RR |
|---|---|---|---|---|---|---|---|---|---|---|
| External exposure to TCDD and cancer incidence (exposure incidence) | ||||||||||
| 1 | Kogevinas | Part of IARC | 1955–1988 | Occupational | Job and company | All cancers, | F | 29/701 | N/A | 2.22 |
| 2 | Read | New Zealand | 1970–2001 | Nonoccupational | Individual | All cancers | F/M | 8013/375,583 | N/A | 0.91–1.11 |
| 3 | Pesatori | Italy, Seveso | 1977–1996 | Industrial | Measurements | All cancers | F/M | 2122/218,761 | 0–74 | Zone A: 1.03 |
| Blood level of TCDD and cancer incidence (blood incidence) | ||||||||||
| 4 | Pavuk | USA, Vietnam | 1982–2003 | Vietnam war | Physical examinations | All cancers | M | 402/1482 | Mean 63.7 | 1.6 |
| 5 | Warner | Italy, Seveso, SWHS | I:1976–1996, | Industrial | Interviews, physical and blood samples, and sample examination | All cancers, | F | 66/981 | 0–40 | 2.77 |
| 6 | Ott | Germany, | 1959–1992 | Occupational | Questionnaires and blood samples | All cancers | M | 31/243 | N/A | 1.3 |
Analysis of the association between external exposure to TCDD and cancer incidence. Reproduced from Xu et al. [14], published by Sci. Rep., 2016.
| Type of Cancer | Pooled Risk | 95% CI |
|---|---|---|
| All cancers | 1.01 | 0.97–1.06 |
| Soft tissue sarcoma | 1.37 | 0.97–1.93 |
| Hodgkin’s Lymphoma | 1.13 | 0.83–1.54 |
| Non-Hodgkin’s Lymphoma | 1.09 | 0.92–1.30 |
Risk ratio (RR) of cancer among Vietnamese veterans exposed to dioxins in the years 1962–1975.
| Exposed Group | Unexposed Group | Risk Ratio | ||||
|---|---|---|---|---|---|---|
| Diseases | Number | Incidence (%) | Number | Incidence (%) | RR | 95% CI |
| All cancers | 1262 | 4.38 | 220 | 1.15 | 3.80 | 3.29–4.38 |
| Soft tissue sarcoma | 54 | 0.19 | 5 | 0.03 | 7.15 | 2.86–17.87 |
| Hodgkin’s Lymphoma | 58 | 0.20 | 3 | 0.02 | 12.80 | 4.01–40.83 |
| Non-Hodgkin’s Lymphoma | 142 | 0.49 | 29 | 0.15 | 3.24 | 2.17–4.83 |
| Carcinomas of the lung, bronchus, and trachea. | 577 | 2.00 | 111 | 0.58 | 3.44 | 2.81–4.21 |
| Prostate cancer | 164 | 0.57 | 37 | 0.19 | 2.93 | 2.05–4.19 |
| Liver cancer | 267 | 0.93 | 35 | 0.18 | 5.05 | 3.55–7.18 |
Note: Data from Le et al. (2007) [25].
Numbers and incidence of cancer among residents exposed to Agent Orange living in some of the provinces of South Vietnam.
| Type of Cancer | Number | Incidence (%) |
|---|---|---|
| All cancers | 163 | 9.73 |
| Lung cancer | 17 | 1.01 |
| Liver cancer | 23 | 1.37 |
| Kidney cancer | 34 | 2.03 |
| Prostate cancer | 69 | 6.23 |
| Ovary cancer | 7 | 1.23 |
| Uterine cancer | 13 | 2.29 |
Note: Data from Nguyen et al. (2021) [27] with 1675 participants including 1107 men and 568 women.
Comparison of cancer incidence risk ratio for Vietnamese people with people from other countries exposed to dioxins.
| Type of Cancer | Risk Ratio | Risk Ratio | RRVietnam |
|---|---|---|---|
| All cancers | 3.80 | 1.01 | 3.76 |
| Soft tissue sarcoma | 7.15 | 1.37 | 5.22 |
| Hodgkin’s Lymphoma | 12.80 | 1.13 | 11.33 |
| Non- Hodgkin’s Lymphoma | 3.24 | 1.09 | 2.97 |
| Lung cancer | 3.44 (4.40) | No data | - |
| Prostate cancer | 2.93 (21.24) | No data | - |
| Liver cancer | 5.05 (7.48) | No data | - |
Note: Data (*) from study of Le et al. (2007) [25], data in parentheses from Nguyen et al. (2021) [27], and (**) from Xu et al. (2016) [14].